Cancer, a peer-reviewed journal of the American Cancer Society, has announced the appointment of Dr. Fadlo Khuri as the new Editor-in-Chief of the journal. Dr. Khuri will begin his term on September 1, 2011. He succeeds Dr. Raphael E. Pollock, who leaves the position after 11 years of service. Dr. Khuri has accepted a 5-year term for the editorship.
Dr. Khuri is Professor and Chair of Hematology and Medical Oncology at Emory University, the Deputy Director for the Winship Cancer Institute of Emory University, and Roberto C. Goizueta Distinguished Chair in Cancer Research. He has served as editor for the journal's lung section since 2005. His clinical interests include thoracic and head and neck oncology. His research interests include development of molecular, prognostic, therapeutic, and chemopreventive approaches to improve the standard of care for patients with tobacco-related cancers.
Dr. Khuri also serves as a grant reviewer for the American Cancer Society, National Cancer Institute, the American Association for Cancer Research, and the American Society of Clinical Oncology. He has published more than 200 peer-reviewed articles and has received numerous awards, including the Nagi Sahyoun Award from the Middle East Medical Assembly and the Waun Ki Hong Award from MD Anderson Cancer Center for his work on targeting signaling pathways in lung and aerodigestive cancers.
Published by Wiley-Blackwell, Cancer is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of the journal is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology and course of human cancer.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
